Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Zhong-Hai Ren · SciRah

Researcher profile · Semantic Scholar

Zhong-Hai Ren

Share profile

Zhong-Hai Ren — researcher profile on SciRah

h-index: 5
Works: 11
Citations: 187

Most-cited papers

Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial.
Xiang-Rui Meng, Tao Wu, Yong-Gui Hong, Q. Fan +20 more
2022The Lancet Gastroenterology and Hepatology76 citations
Semantic Scholar
Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer.
Ying Liu, Zhong-Hai Ren, Long Yuan, Shu-Ning Xu +3 more
2016American Journal of Cancer Research69 citations
Semantic Scholar
Clinical Implication of Elevated Human Cervical Cancer Oncogene-1 Expression in Esophageal Squamous Cell Carcinoma
Ying Liu, Ke Li, Zhong-Hai Ren, Sheng-Lei Li +2 more
2012Journal of Histochemistry and Cytochemistry13 citations Open access
Semantic Scholar
Comparison of Helicobacter pylori positive and negative gastric cancer via multi-omics analysis
Fumei Shang, Ying-Hao Cao, Lixin Wan, Zhong-Hai Ren +3 more
2023mBio12 citations Open access
Semantic Scholar
Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer
Ying Liu, Zhong-Hai Ren, Shu-Ning Xu, H. Bai +2 more
2015Cancer Chemotherapy and Pharmacology8 citations Open access
Semantic Scholar
[Effect of circ-SFMBT2 on the biological behavior of non-small cell lung cancer cells by targeting the miR-7-5p/ADAM10 axis].
Changsheng Li, Guanping Zhang, Zhong-Hai Ren
2022Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics3 citations
Semantic Scholar
Camrelizumab in combination with apatinib as second-line treatment for advanced esophageal squamous cell carcinoma: A single-arm, open-label, phase II study.
Feng Wang, Jun-Sheng Wang, Tao Wu, Yong S. Hong +7 more
20213 citations
Semantic Scholar
The clinical observation of combined chemotherapy of irinotecan and cisplatin in the treatment of relapsed advanced small cell lung cancer
Zhong-Hai Ren, Cheng-Hui Zhang, Ming Li
20083 citations
Semantic Scholar
659 AN SINGLE-ARM OPEN-LABEL PHASE II STUDY OF CAMRELIZUMAB PLUS APATINIB AS SECOND-LINE TREATMENT FOR ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Feng Wang, Q. Fan, Jun-Sheng Wang, Tao Wu +13 more
2021Diseases of the esophagus0 citations
Semantic Scholar
Occurrence rate of preoperative nutritional risk,malnutrition and the current status of clinical nutritional support of patients with esophageal cancer
Zhong-Hai Ren
20130 citations
Semantic Scholar
Clinical study of thalidomide plus PF regimen in the treatment of advanced esophageal cancers
Zhong-Hai Ren
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Q. Fan×4
Invite
Q. Fan — researcher profile on SciRah
Feng Wang×4
Invite
Feng Wang — researcher profile on SciRah
Xiang-Rui Meng×3
Invite
Xiang-Rui Meng — researcher profile on SciRah
Tao Wu×3
Invite
Tao Wu — researcher profile on SciRah

×3

Invite

Yan-Zhen Guo — researcher profile on SciRah

Invite

Xiu-Li Yang — researcher profile on SciRah

Invite

Pei Shi — researcher profile on SciRah

Jia-Mei Yang×3

Invite

Jia-Mei Yang — researcher profile on SciRah

Jun-Sheng Wang×3

Invite

Jun-Sheng Wang — researcher profile on SciRah

Xian-Zhe Yin×2

Invite

Xian-Zhe Yin — researcher profile on SciRah

Invite

Zhi-Yu Luo — researcher profile on SciRah

Invite

Jin Xia — researcher profile on SciRah